company · 7 records
Cipla
GLP-1 boom pushes pharma companies into wellness and nutraceuticals
Pharmaceutical companies are expanding into wellness and nutraceutical products to complement the growing use of GLP-1 weight-loss medications.
Indian stock markets rise over one percent amid global cues
The Indian stock market gained over 1% on July 27th, recovering from a week of declines with Sensex rising over 800 points amid falling oil prices and eased geopolitical tensions.
Authorities seal factory producing counterfeit medicines in Dehradun
Uttar Pradesh authorities and Ghaziabad police sealed a Dehradun factory producing counterfeit drugs using names of major pharmaceutical companies.
Infosys and IndiGo among sixty companies reporting first quarter earnings today
Infosys, IndiGo, Cipla, PVR Inox, and IEX are among more than 60 companies set to announce Q1FY27 earnings results on July 23.
IndiGo Infosys Cipla Meesho and Mphasis release first quarter earnings today
IndiGo, Infosys, Cipla, Meesho, and Mphasis are releasing Q1 earnings results today, with IndiGo's consolidated revenue projected to rise 19% year-on-year.
Indian stock markets decline following US tariff proposal on generic drugs
Indian stock markets fell sharply after Donald Trump announced plans to impose tariffs of up to 200% on imported generic drugs, dragging Sensex and Nifty down with pharmaceutical stocks hit hardest.
Trump announces phased tariff increases on imported generic medicines
President Donald Trump announced a phased tariff plan on imported generic medicines that will keep duties at zero for two years before rising to 100% and then 200% to push pharmaceutical production back to the United States, with major implications for Indian drug exporters.